Fig. 5From: FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization(A) The flow cytometry results showed that iNOS expression was significantly increased in the Caov3−shFPR2 group compared with the control group and was significantly decreased in the OVCAR3−FPR2+ group compared with the control group (*P < 0.05). (B) CD206 expression was significantly increased in the OVCAR3−FPR2+ group compared with the control group and was significantly decreased in the Caov3−shFPR2 group compared with the control group (*P < 0.05)Back to article page